Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery… Read More
Friday ID Conference: Dynamics and Clinical Relevance of Drug Resistant HIV
This talk is a part of our friday morning CFAR/IGHID Friday ID Conference Series. “Dynamics and Clinical Relevance of Drug Resistant HIV; the end of the problem” Speaker: Charles Boucher… Read More
HIV DART 2014: “Frontiers in Drug Development for Antiretroviral Therapies”
HIV DART 2014 Conference: “Frontiers in Drug Development for Antiretroviral Therapies” December 9-12, 2014, Los Cabos, Mexico The focus of HIV DART 2014 is to assemble clinicians, nurses, researchers and… Read More
